| Dr Carl M Higuchi, MD | |
|
98211 Moanalua Road, Suite 320, Aiea, HI 96701 | |
| (808) 487-7447 | |
| (808) 487-7557 |
| Full Name | Dr Carl M Higuchi |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 42 Years |
| Location | 98211 Moanalua Road, Aiea, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659348597 | NPI | - | NPPES |
| 06090601 | Medicaid | HI | |
| 06090603 | Medicaid | HI | |
| 0080887 | Other | HI | HMSA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD7219 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Queens Medical Center | Honolulu, HI | Hospital |
| Pali Momi Medical Center | Aiea, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Queens University Medical Group | 2466831557 | 543 |
| The Queens Medical Center | 3476454067 | 187 |
News Archive
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carl M Higuchi, MD 98211 Moanalua Road, Suite 320, Aiea, HI 96701 Ph: (808) 487-7447 | Dr Carl M Higuchi, MD 98211 Moanalua Road, Suite 320, Aiea, HI 96701 Ph: (808) 487-7447 |
News Archive
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
As the leading cause of death in both the United States and the world, heart disease claims nearly 18 million lives every year, according to the World Health Organization.
Linagliptin has been approved since August 2011 to improve blood glucose control in adults with type 2 diabetes mellitus whose elevated blood glucose levels are inadequately controlled by diet and exercise.
› Verified 4 days ago
Dr. Dawn A. Miura, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 350, Aiea, HI 96701 Phone: 808-487-2277 Fax: 808-488-5582 | |
Dr. Michael Wayne Chan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 655, Aiea, HI 96701 Phone: 808-486-6200 | |
Dr. Craig Yoshio Hamasaki, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1247 Kaahumanu Street, Suite 224, Aiea, HI 96701 Phone: 808-486-9119 Fax: 808-486-9401 | |
Dr. Kevin Scott Hara, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Suite 430, Aiea, HI 96701 Phone: 808-484-2000 Fax: 808-488-6580 | |
Shayne Mark Castanera, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Aiea, HI 96701 Phone: 808-486-6000 | |
Dr. Ky H Le, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-199 Kamehameha Hwy Unit C-10b, Aiea, HI 96701 Phone: 808-954-4500 Fax: 808-758-0146 | |
Dr. Malissa Hyun Kyung Iida-takashima, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 98-1079 Moanalua Rd, Ste 500, Aiea, HI 96701 Phone: 808-488-0990 |